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ABSTRACT 
Hydrogels are cross linked, three-dimensional hydrophilic polymers, which swell without dissolving 
when brought into contact with water or other biological fluids. The water content which makes 
hydrogel such a special class of materials is also responsible for their biggest disadvantage of the poor 
mechanical properties. Hydrogel with better mechanical properties could be obtained through the 
preparation of interpenetrating polymer network. Interpenetrating polymer network hydrogel of 
cefadroxil (antibiotic) is prepared by chemical cross linking method using chitosan and poly vinyl 
pyrrolidone polymers and glutaraldehyde as cross linking agent. Then, the interpenetrating polymer 
network hydrogel was evaluated. From Fourier transfer infrared spectroscopy it was concluded that 
there is no interaction between exicipients and drug which confirm the stability of the drug in the 
formulation. In vitro drug release studies shows that interpenetrating polymer network hydrogel 
formulation controlled the drug release up to 36 hours. From swelling studies it is concluded 
formulation which is formulated can absorb large amount of water and have good swelling property. X- 
ray diffraction patterns recorded confirm the amorphous nature of the drug after encapsulating in 
formulation. Scanning electron microscopy shows that the unswollen interpenetrating polymer 
hydrogel appeared to be in smooth surface and swollen interpenetrating polymer hydrogel showed 
roughed nature and porous surface. From the in-vitro release kinetic study it was observed that data 
was found to fit best into the zero order release model. Stability studies were also conducted and results 
were found to be stable for six months at 4°C ± 2°C, 25°C±2°C/60%±5% RH and 40°C±2°C/75%±5% 
RH. The result showed that interpenetrating polymer network hydrogel release the drug in controlled 
manner for prolong period of time thus maintain the concentration of Cefadroxil in body.  
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Introduction 
Oral drug delivery is the most widely utilized 
route of administration among all the routes 
that have been explored for systemic delivery 
of drugs via pharmaceutical products of 
different dosage form. Oral route is considered 
the most natural, convenient and safe due to its 
ease of administration, patient acceptance, and 
cost effective manufacturing process. 
Pharmaceutical products designed for oral 
delivery are mainly immediate release type or 
conventional drug delivery systems, which are 
designed for immediate release of drug for 
rapid absorption. Conventional drug delivery 
suffer from certain drawbacks like increased 
fluctuation in the circulatory drug level, more 
frequency of dosage administration, increased 
G.I. irritation and dose related side effects. To 
overcome these disadvantages, control release 
oral drug delivery systems were 
designed[1,2].Controlled release drug delivery 
system is the one which delivers the drug at a 
predetermined rate, locally or systemically for 
a specified period of time[3].Hydrogel are 
three-dimensional networks composed of 
hydrophilic polymers cross linked through 
covalent bonds or held together via physical 
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intermolecular attractions. Hydrogel can 
absorb large amounts of water or biological 
fluids, from 20% up to several thousand 
percent and swell readily without dissolving. 
The high hydrophilicity of the hydrogel is 
mainly due to the presence of a number of 
hydrophilic moieties such as amino, carboxyl, 
amide and hydroxyl groups distributed along 
the backbone of the polymeric strands. In the 
swollen state the hydrogel are soft and have a 
rubbery structure, resembling to a great extent 
to the living tissues.Some hydrogel, such as 
alginate-based gels, also offer excellent 
biocompatibility[4,5]. The main objective of 
the study was to develop Interpenetrating 
polymer network hydrogel .The hydrogel 
formulation must give controlled release of 
drug by which half life of drug increases and it 
also leads to increase in bioavailability.  
In the present research, interpenetrating 
polymer network hydrogel of cefadroxil was 
prepared followed by the optimization and the 
evaluation of the prepared formulation. The 
ultimate aim was to improve bioavailability of 
the drug and to improve the market 
formulation. 
 
Material and Methods 
Preparation of Interpenetrating Polymer 
Network Hydrogel 
Interpenetrating polymer network hydrogel 
was prepared by chemical cross linking 
method. Chitosan solution (2%, w/v) was 
prepared in 0.1 M glacial acetic acid. Poly 
vinyl pyrrolidone solution (4%, w/v) was 
prepared in double distilled water. Different 
ratios of these solutions were mixed to form a 
blend which was given in table no. 1. A 
specific amount of cefadroxil was added in 
each formula before cross-linking. 
Glutaraldehyde solution was used as a cross-
linking agent and added at a concentration of 
4% (v/v) to the chitosan- Poly vinyl 
pyrrolidone mixture to form interpenetrating 
polymer network hydrogel. The solution 
obtained was poured into Petri dish and kept 
overnight for cross linking at room 
temperature. The cross linked hydrogel 
obtained was then cut into 1×1 cm
2 
pieces and 
dried for 24 h at 40ºC under vacuum. The dried 
interpenetrating polymer network hydrogel 
were crushed and passed through sieve 
No.60/85. The interpenetrating polymer 
network hydrogel retained on sieve No.85 
were taken for further studies. We made twelve 
different formulations by varying the amount 
of polymer, amount of drug and amount of 
cross linking agent (glutaraldehyde) and 
formulae for the preparation of interpenetrating 
polymer network hydrogel are listed in table 
no. 1 below[6,7]. 
 
Table No. 1: Composition of hydrogels 
Formulation 
Code  
 
Chitosan  
(1% w/v) ml 
Poly Vinyl 
Pyrrolidone  
(2% w/v) ml  
Drug  
(mg)  
Glutaraldehyde  
(4% v/v) ml  
A- 1 20 70 150  2.5  
A-2 40 70 150  2.5  
A-3 60 70 150  2.5  
A-4 60 60 150  2.5  
A-5 60 50 150  2.5  
A-6 60 40 150  2.5  
A-7 60 40 100 2.5  
A-8 60 40 200 2.5  
A-9 60 40 250 2.5  
A-10 60 40 250 5 
A-11 60 40 250 7.5 
A-12 60 40 250 9 
 
Evaluation Of Ipn Hydrogel of Cefadroxil 
Percentage Yield 
The yield was calculated by dividing the 
weight of collected IPN hydrogel by the 
weight of non-volatile compound used for the 
preparation of IPN hydrogel. The percentage 
yield was then calculated using formula given 
below[8]. 
Percentage yield = 
𝑇ℎ𝑒𝑜𝑡𝑟𝑖𝑐𝑎𝑙 𝑦𝑖𝑒𝑙𝑑
𝑃𝑟𝑎𝑐𝑡𝑖𝑐𝑎𝑙  𝑦𝑖𝑒𝑙𝑑
 × 100 
Drug Entrapment Efficiency (%) 
Here an amount of hydrogel containing 100 
mg of cefadroxil was placed in 50 ml distilled 
water for 24 hours. In the distilled water the 
hydrogel swelled. The swollen hydrogel were 
crushed in an agate mortar with a pestle and 
the homogeneous solution formed was 
sonicated for 2 min at 60 MHz frequency. 
About 50 ml of water was added to precipitate 
the blend polymer, which was then removed 
with water using a high-speed centrifuge for 5 
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min at the rotation speed of 10,000 rpm after 
that filter the solution. The amount of 
cefadroxil was analyzed using UV 
spectrophotometer at the absorption maxima 
value of 230 nm. The percentage encapsulation 
efficiency was calculated using the following 
equations, respectively[9]. 
Entrapment Efficiency (%) = 
𝑇𝑜𝑡𝑎𝑙 𝑎𝑚𝑜𝑢𝑛𝑡 𝑜𝑓 𝑑𝑟𝑢𝑔 𝑟𝑒𝑐𝑜𝑣𝑒𝑟𝑒𝑑
𝑇𝑜𝑡𝑎𝑙 𝑎𝑚𝑜𝑢𝑛𝑡 𝑜𝑓 𝑑𝑟𝑢𝑔 𝑎𝑑𝑑𝑒𝑑
× 100 
 
In- Vitro Release Studies 
Dissolution experiments were performed at 
37ºC using a dissolution tester equipped with 
six paddles at a paddle speed of 100 rev. /min. 
A 900 ml solution of phosphate buffer solution 
(Ph7.4) was used as a dissolution medium in 
order to simulate the gastrointestinal tract 
(GIT) conditions. An aliquot (10ml) was 
withdrawn at specific time intervals and 
replenished with an equivalent volume of 
dissolution fluid. Whenever necessary, the 
samples were diluted before assaying 
cefadroxil. Drug content was determined by 
UV-spectroscopy at 230 nm. Percentage drug 
release was calculated using an equation 
obtained from calibration curve[10]. 
 
Fourier Transform Infra Red Spectroscopy 
Fourier Transform Infrared Spectroscopy was 
used for structure analysis and compatibility 
study of drug with polymer. The FTIR spectra 
of pure chitosan, pure PVP, pure drug, and 
formulation were recorded using FTIR 
spectrophotometer. The KBr disc technique 
was employed. Since the KBr has no 
absorption in the fundamental region of IR 
spectrum, only the spectrum of sample is 
obtained. The sample and the dry KBr in ratio 
1:100 were taken on a dye set and pressure up 
to 100Kg/cm2 applied on the dye set with the 
help of hydraulic press and put it for 5 min, 
before releasing pressure .The pellet was put in 
a pellet holder and transferred to FTIR 
instrument and spectrum of sample was taken 
at 4000- 400 cm
-1
 [11]. 
 
Scanning Electron Microscopy  
The formulations were characterized for their 
shape and surface morphology. Surface 
morphology of IPN hydrogel in unswollen and 
swollen (water) state after drying were 
examined separately. SEM studies were carried 
out on hydrogel samples. The hydrogel 
particles (sample) were mounted on metal 
stubs using double sided tape and these 
particles were coated with gold to a thickness 
of about 450 Å using sputted gold coater and 
visualized under Scanning electron 
microscope.  
 X-Ray Diffraction (X-Rd)  
X-ray diffraction (XRD) is a tool for 
determining the molecular structure and 
crystallinity of a material by obtaining 
information about lattice parameters. The 
principle is to bombard the sample with an X-
ray beam with different incoming angles 
generating a diffraction pattern. Constructive 
interference is observed when Bragg’s law 
(eq.) is fulfilled resulting in peaks in the 
diffraction pattern.  
                           2𝑑sin𝜃=𝑛𝜆                                                                                
(eq.)  
Where n is any integer, θ is the scattering 
angle, λ is the wavelength of the X-rays. The 
obtained data can be compared with the Joint 
Committee on Powder Diffraction Standards 
registry to determine the crystal structure of 
the material. X-RD was used to determine the 
crystallinity of Cefadroxil encapsulated in the 
A-10 hydrogel formulation.  
X-RD analysis can provide a clue about 
crystalline or amorphous nature of the drugs 
after encapsulation in Interpenetrating polymer 
network hydrogel. X-RD patterns recorded for 
plain drug and drug loaded Interpenetrating 
polymer network hydrogel using X-ray 
diffractometer (Xpert-Pro). The dried 
Interpenetrating polymer network hydrogel of 
uniform size were mounted on a sample holder 
and X-RD scanning was recorded up to 2θ at 
25°C using Copper as radiation source to 
estimate crystallinity/amorphous nature of the 
samples[12]. 
 
 Swelling Studies  
Swelling studies of IPN hydrogel were done as 
dynamic equilibrium study. In dynamic 
swelling experiment IPN hydrogel were placed 
in distilled water at 37±2°C. During swelling 
hydrogel removed from the water bath at 
regular time intervals and after drying 
superficially with filter paper, and weighted 
,they were return into the same swelling bath 
the swelling study was done untilled no more 
swelling (equilibrium swelling). The swelling 
ratio can be calculated as function of time and 
it can be calculated from following relationship 
Percentage Swelling Index = 
𝑊𝑆−𝑊𝐷
𝑊𝐷
× 100 
W
S 
– Weight of hydrogel in swollen state at a 
given time  
W
D 
– Weight of hydrogel at dry state[13].  
 
In Vitro Drug Release Kinetics  
The mechanism of drug release from the 
dosage form is an important factor. There are 
several mechanisms by which drug released 
from dosage form such as controlled release, 
delayed release, immediate release and 
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pulsatile release. For this purpose, the use of 
mathematical modeling approach to be very 
useful because this enables the prediction of 
release kinetics. More often, it allows the 
measurement of some important physical 
parameters, such as the drug diffusion 
coefficient. There are several models which 
represent the drug dissolution profiles;  
 Zero order release kinetics  
 First order release kinetics  
 Higuchi model  
 Korsmeyer- peppas model  
 
Zero order release kinetics  
Zero order release kinetic is mainly applicable 
for the process of constant drug release. The 
plot was made in between cumulative percent 
drug release vs. Time (zero order kinetic 
models). Ideal delivery of drugs would follow 
zero order kinetics, where in blood levels of 
drugs would remain constant throughout the 
delivery period. This relationship can be used 
to describe the drug dissolution of several 
types of modified release pharmaceutical 
dosage forms.  
                           Q
t 
= Q
o
K
o
t  
Where , Q
t 
is the initial amount of drug 
dissolved at time t; Q
o 
is the amount of the 
drug in the solution, most of the times it is 
equal to zero; K
o 
is the zero order release rate 
constant. To study the release kinetics, data 
obtained from in vitro drug release studies 
were plotted as percentage cumulative amount 
of drug released versus time 
 
First order release kinetics  
This relationship can be used to describe the 
drug dissolution in pharmaceutical dosage 
forms such as those containing water-soluble 
drugs in porous matrices. The data obtained 
were plotted as log cumulative percentage of 
drug remaining vs. Time. The release of the 
drug which followed first order kinetics can be 
expressed by equation:  
            Q
t 
= Q
o
e
-kt 
or ln (Q
T
/Q
o
) =K
l
t  
Where, Q
t 
is the initial amount of drug 
dissolved at time t; Q
o 
is the amount of drug in 
the solution; K
l 
is the first order release rate 
constant.  
 
Higuchi model  
This model is based on the hypotheses that  
I. Initial drug concentration in the matrix 
is much higher than drug solubility.  
II. Drug diffusion takes place only in one 
dimension.  
III. Drug particles are much smaller than 
system thickness.  
IV. Matrix swelling and dissolution are 
negligible.  
V. Drug diffusivity is constant.  
VI. Perfect sink conditions are always 
attained in the release environment.  
 
According, model expression is given by the 
equation:  
                                Q
t 
= Kt 
Where, Q
t 
is the initial amount of drug 
dissolved in the time t; K is Higuchi release 
constant. The plot was made in between 
cumulative percentage drug release vs. Square 
root of time.  
 
Korsmeyer-peppas model  
Korsmeyer derived a simple relationship which 
described drug release from a polymeric 
system. To find out the mechanism of drug 
release, first 60% drug release data were fitted 
in Korsmeyer-peppas model. The plot made 
was made log cumulative percentage drug 
release vs. Log time  
M
t
/M
∞
=Kt
n
 
Where M
t
/M
∞ 
is fraction of drug released at 
time t; K is the rate constant and n is the 
release exponent. The plot was made between 
log of percentage cumulative drug released vs. 
Log time[14].  
 
Stability Studies  
Stability studies represent a vital part of any 
development program for pharmaceutical 
products .Stability is defined as the capacity of 
a drug substance or drug product to remain 
within the established specification to maintain 
its identity, strength, quality and purity 
throughout the retest or expiration dating 
period. The objective of the stability study is to 
determine the self life, namely the time period 
of the storage at a specific condition with in 
which the drug product still meets its 
established specification[15].  
Stability studies consist of a series of tests in 
order to obtain an assurance of stability of a 
drug product, namely maintenance of the drug 
product packed in it specified packing material 
and stored in the established storage condition 
with in the determined time period. Proper 
design, implementation, monitoring and 
evaluation of the studies are crucial for 
obtaining useful and accurate stability data. 
Stability studies are takes place according to 
ICH guidelines.  
ICH specifies the length of study and 
storage condition:-  
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Long term testing 25ºC ± 2ºC/60% RH ± 5% 
for 12 months  
Short term study 40ºC ± 2ºC/75% RH± 5% for 
6 months 
Method  
Stability studies were conducted on optimized 
formulation of IPN hydrogel at 4ºC± 2ºC, 25ºC 
± 2ºC/60%±5% RH and 40ºC ± 2ºC/75% RH ± 
5% as per ICH Q1A (R2) regulations for 6 
months. Formulation was kept in screw capped 
amber coloured bottle. During the period of 
storage after a specific time period (2 month, 4 
months and 6 months) the IPN hydrogel were 
subjected to following test: physical 
appearance, Drug entrapment efficiency and 
percentage cumulative drug release. Stability 
studies of optimized formulation in all three 
conditions were carried out in triplicate[16,17]. 
 
 
 
Results and Discussion 
Percentage Yield, Drug Entrappment 
Efficiency And Percentage Cumulative 
Drug Release 
In formulation A-1, A-2 and A-3 when 
concentration of chitosan was increased 
increase in drug entrapment efficiency, 
percentage yield and percentage cumulative 
drug release is shown. In formulation (A-4, A-
5 and A-6) with decrease in PVP concentration 
the drug entrapment efficiency, percentage 
yield and percentage cumulative drug release 
increases. From all the above we conclude that 
as the concentration of chitosan increase drug 
entrapment efficiency, percentage yield and 
percentage cumulative drug release increase 
but in other hand decrease in concentration of 
PVP leads to increase in drug entrapment 
efficiency, percentage yield and percentage 
cumulative drug release in formulation A-1 to 
A-6. In another set of formulations, we can see 
that as the concentration of drug decrease drug 
entrapment efficiency, percentage yield and 
percentage cumulative drug release also 
decreases as shown in formulation A-7 but 
further increase in drug quantity lead to 
increase in drug entrapment efficiency, 
percentage yield and percentage cumulative 
drug release. From all this we can observe as 
the concentration of drug increases it leads to 
increase in drug entrapment efficiency, 
percentage yield and percentage cumulative 
drug release. We can conclude that A-9 
formulation contains highest drug entrapment 
efficiency, percentage yield and percentage 
cumulative drug release so this is optimized 
amount of drug (250 mg) which we used in 
preparation of optimized formulation. That as 
the concentration of cross linking agent 
increases drug entrapment efficiency increase 
but in case of percentage yield and percentage 
cumulative drug release firstly it increases (A-
9 to A-10) after that in formulation A-11 and 
A-12 it decrease. The decrease in percentage 
cumulative drug release is due to more 
addition of cross linking agent due to which 
drug cannot be completely release from the 
formulation and bind in network of polymers. 
 
Table No. 2: Results of percentage yield, drug entrapment efficiency and percentage cumulative 
drug release 
Formulation 
Code 
Drug Entrapment  
Efficiency (%) (±S.D)  
Percentage yield (%)  
(±S.D)  
Percentage Cumulative 
Drug Release in time  
(±S.D)  
A-1 64.142±0.64  77.276±0.92  94.78±1.96 in 8 hours  
A-2 68.527±0.95  79.023±0.85  91.432±1.99 in 12 hours  
A-3 69.372±1.43  81.218±0.93  79.107±1.94 in 18 hours  
A-4 70.381±1.69  80.012±1.42  83.29±1.88 in 18 hours  
A-5 71.050±1.92  82.245±1.66  87.294±1.95 in 18 hours  
A-6 72.520±0.91  83.047± 0.90  89.538±1.98 in 24 hours 
A-7 66.726±1.42  78.54±1.42  75.542±1.90 in 18 hours  
A-8 77.247±1.15  86.528±1.26  90.518± 1.93 in 24 hours  
A-9 87.613±0.73  89.013±0.82  93.435±1.94 in 30 hours  
A-10 90.710±0.37  96.805±0.36  96.78±1.89 in 36 hours  
A-11 91.896±0.48  94.011±0.49  87.238±1.81 in 36 hours  
A-12 92.812±0.22  90.054±0.51  84.0424±1.88 in 36 hours  
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Figure No. 1: Percentage (Drug entrapment efficiency & Percentage Yield) vs. formulation code 
graph of IPN Hydrogel formulations (A-1 to A-6) 
 
Figure No. 2: Percentage (Drug entrapment efficiency & Percentage Yield) vs. formulation code 
graph of IPN Hydrogel formulations (A-6 to A-9) 
 
Figure No. 3: Percentage (Drug entrapment efficiency & Percentage Yield) vs. formulation code 
graph of IPN Hydrogel formulations (A-9 to A-12) 
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In- Vitro Drug Release Studies 
In vitro drug release study was carried out for 
all the formulation in phosphate buffer of pH 
7.4 by using dissolution apparatus (paddles 
type). The obtained result were tabulated in 
Table no. 3, 4 and graphically represented in 
Figure no. 4, 5. Out of all the formulation A-10 
formulation gives us prolonged drug release 
(36 hours) with good drug entrapment 
efficiency (90.710±0.37), percentage yield 
(96.805±0.36) and percentage cumulative drug 
release (96.78±1.89). So A-10 is the optimized 
formulation. 
 
Table No. 3: Percentage cumulative drug release with standard deviation of formulations i.e. A-1, 
A-2, A- 3, A- 4, A- 5 and A-6 
Time 
(hrs) 
A-1 A-2 A-3 A-4 A-5 A-6 
0 0 0 0 0 0 0 
1 8.131±2.21 12.033±2.0 7.231±2.23 8.908±0.22 6.567±1.41 5.275±1.62 
2 18.01±2.32 24.231±2.83 19.326±2.40 10.991±0.43 13.215±1.54 9.622±1.85 
3 28.46±2.42 9.455±2.64 30.338±2.61 15.512±0.61 25.337±1.67 17.535±1.13 
4 40.45±2.54 51.64±2.71 45.157±2.83 32.395±1.81 38.981±1.89 30.234±1.56 
6 57.07±2.63 62.74±2.97 54.092±2.12 49.523±1.17 49.592±1.74 41.899±1.74 
8 94.78±2.71 77.01±2.69 65.725±2.27 60.318±1.29 69.329±2.13 55.414±1.69 
12 - 91.43±3.12 71.381±2.34 77.226±1.42 79.784±2.23 68.353±2.32 
18 - - 79.107±2.46 83.29±1.68 87.29±2.42 75.867±2.95 
24 - - - - - 89.538±3.0 
30 - - - - - - 
36 - - - - - - 
 
 
 
 
 
 
 
 
 
 
Figure No. 4: Percentage Cumulative release vs. time graph of IPN Hydrogel formulations (A-1 
to A-6) 
 
 
Table No.4 Percentage cumulative drug release with standard deviation of formulations i.e. A-7, 
A-8, A-9, A-10, A-11 and A-12 
Time  
(hrs)  
A-7  A-8  A-9  A-10  A-11  A-12  
0 0 0 0 0 0 0 
1 10.895 ±0.67 9.254±1.92  6.702±1.23  5.433±0.32  5.212±0.42  3.442±0.22  
2 16.134±0.89  11.327±2.12  8.326± 1.42  6.411±0.37  7.931±0.65  5.541±0.35  
3 25.265±1.0  19.375±2.31  16.318±1.67  8.788±0.48  13.043±1.23  12.309±0.63  
4 30.538±1.54  35.816±2.21  25.591±1.86  10.003±0.56  18.527±1.52  15.371±0.98  
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6 47.916±1.72  52.518±2.41  34.764±2.14  14.338±0.83  26.395±1.64  21.722±1.29  
8 54.724±1.69  69.836±2.52  58.04±2.29  18.521±0.99  32.409±1.69  26.485±1.45  
12 65.259±1.32  78.452±2.63  69.889± 2.31  25.348±1.43  49.723±1.32  42.99±1.61  
18 75.542±1.95  84.275±2.12  80.387±2.45  41.289±1.65  62.401±1.55  56.326±1.79  
24 -  90.518±2.26  86.628±2.52  58.629±1.87  71.192±1.73  62.907±1.96  
30 -  -  93.435±2.65  74.325±1.98.  81.281±1.89  78.106±2.06  
36 -  -  -  96.78±2.22  87.238±1.92  84.0424±2.24  
 
 
 
 
 
Figure No. 5: Percentage Cumulative release vs. time graph of IPN Hydrogel formulations (A-7 
to A-12) 
Fourier Transform Infra Red Spectroscopy 
Polymers, drug as well as the optimized 
formulations were characterized by FTIR 
spectroscopy to know any possible interaction 
between drug, polymer and the cross linking 
agent (figure no. 6, 7, 8, 9 and 10). The FTIR 
spectrum of chitosan showed strong peaks in 
the range 3700–3500 cm
-1
peaks corresponding 
to O‐H stretching at 3453.12 cm
-1 
and amine 
group (NH
2
) stretching at 2918.54 cm
-1 
respectively. Shown in figure 6, PVP shows 
the amide carbonyl stretching band at 1462.81 
cm
-1 
and C-N stretching at 1170.58 cm
-1
. The 
drug cefadroxil showed a broad band at 
1756.12 cm
-1 
due to C=O stretching of 
carboxylic group. The amine group N-H 
stretching band was observed at 1610.64 cm
-1 
and C-O group stretching at 1270.4 cm
-1
. For 
cross-linked chitosan -PVP, an additional peak 
at 1441.59 cm
-1 
can be observed, which 
corresponds to stretching vibrations of C=N 
bond. This strong peak indicates the reaction 
between carbonyl group of glutaraldehyde and 
amine group of chitosan and C-N of PVP 
ensuring the formation of IPN. These all the 
peaks were maintained in formulation at 
3417.95 cm
-1
, 2954.34 cm
-1
, 1462.79 cm
-1
, 
1165.2 cm
-1
, 1758.99 cm
-1
, 1657.96 cm
-1
, 
1290.76 cm
-1 
and 1441.99 cm
-1
. This denotes 
the drug was intact in the formulation and did 
not react either with the polymers or the cross 
linking agent. 
 
Figure No. 6: Fourier transforms infrared spectrum of chitosan 
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Figure No. 7:Fourier transform infrared spectrum of Poly vinyl pyrollidone 
 
Figure No. 8: Fourier transform infrared spectrum of Drug (Cefadroxil) 
Figure No. 9: Fourier transform infrared spectrum of Blank IPN hydrogel formulation 
 
 
Figure No. 10: Fourier transform infrared spectrum of drug loaded IPN hydrogel formulation 
Scanning Electron Microscopy  
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Surface morphology of interpenetrating 
polymer network hydrogel was examined by 
Scanning electron microscopy It was observed 
that hydrogel is irregular in shape and surface 
of unswollen hydrogel was smooth show no 
surface pores (photomicrograph 1). The 
interpenetrating polymer network hydrogel 
kept in distilled water for swelling. After 
drying that swollen IPN Hydrogel showed 
roughed nature and pore on surface of 
interpenetrating polymer network hydrogel 
particles showed in Photomicrograph no. 2. 
 
                                   (a)                                                                   (b) 
Photomicrograph No. 1: SEM images of unswollen IPN hydrogel 
 
                                (c)                                                                  (d)  
Photomicrograph No. 2: SEM images of swollen IPN hydrogel 
 
 
 
 
X- Ray Diffraction 
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Cefadroxil has shown characteristic intense 
peaks at 10.06, 12.3379, 18.8377, 19.0066, 
21.8152, 23.5173, 25.8244, 26.9169, 32.0170, 
34.2332, and 36.4741. These traces reveal the 
crystallinity of the drug. No peaks were found 
in the drug loaded interpenetrating polymer  
network hydrogel because encapsulated drug 
change from crystalline to amorphous state. 
This indicates that most of the drug dispersed 
at molecular level in the polymer matrices 
since no indication about the crystalline nature 
of the drugs was observed in case of drug-
loaded interpenetrating polymer network 
hydrogel. 
Figure No. 11: X-ray diffraction of Drug (Cefadroxil) 
Figure No. 12: X-ray diffraction of IPN hydrogel formulation (A-10) 
Swelling Studies 
Swelling studies of IPN hydrogel were done as 
dynamic equilibrium study. The swelling 
behaviour of particles was expressed as the 
ratio of initial weight of particle to the final 
weight of swollen particles as a function of 
time (Figure no. 13).The Percentage swelling 
Index of Optimized formulation of IPN 
hydrogel was found 650.253±16.60 in 36 
hours. 
Table No. 5: Percentage swelling Index of Optimized formulation (A-10) of IPN hydrogel 
Time (hrs) A-10 (Percentage swelling Index)  
0 0 
1 25.224±12.35  
2 45.912±12.63  
3 76.313± 13.98  
6 110.935± 14.29  
4 140.715± 13.45  
8 179.324±14.61  
12 250.336± 14.96  
18 390.432±16.06  
24 470.691± 15.24  
30 580.829±16.41  
36 650.253±16.60 
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Figure No. 13: Percentage swelling Index of Optimized formulation (A-10) of IPN hydrogel 
In- Vitro Drug Release Kinetics 
To explore and explain the mechanism of drug 
released from the IPN hydrogel. Formulation 
(A-10) was subjected to the various release 
kinetics such as zero order, first order, Higuchi 
model and Korsmeyer-peppas model shown in 
Figure 14, 15, 16 and 17 respectively. 
Zero order release kinetics  
 
 
     
Figure No. 14: Zero order release kinetics of IPN Hydrogel formulation (A-10) 
First order release kinetics 
 
 
Figure No. 15: First order release kinetics of IPN Hydrogel formulation (A-10) 
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Higuchi model 
 
 
              Figure No. 16: Higuchi model release kinetics of IPN Hydrogel formulation (A-10) 
 
 
 Korsmeyer-peppas model 
 
 
Figure No. 17: Korsmeyer-peppas model release kinetics of IPN Hydrogel formulation 
Stability Studies 
The optimized formulation (A-10) was 
preceded further for stability studies. 
Formulation were observed for change in the 
Physical appearance, Entrapment efficiency 
and Percentage cumulative drug release studies 
of IPN hydrogel stored at refrigeration 
temperature (4°C ± 2°C), 25°C±2°C /60% 
±5% RH and 40° C±2°C / 75%±5% RH in 
humidity chamber. 
Table No. 6: Result of IPN hydrogel for stability studies at (4°C ± 2°C) temperature 
Test 2 month 4 month 6 month 
Physical appearance  
 
no change  no change  no change  
Entrapment efficiency 
(%)  
90.121±0.541  89.715±0.989  89.198±0.710  
Table No. 7: Result of IPN hydrogel for stability studies at 25°C±2°C/60±5% RH 
Test 2 month 4 month 6 month 
Physical appearance no change no change no change 
Entrapment efficiency 
(%) 
89.906±0.765  
 
88.872±0.994  88.011±0.671 
 
Table No. 8: Result of IPN hydrogel for stability studies at 40° C±2°C / 75%±5% RH 
Test 2 month 4 month 6 month 
Physical appearance no change no change no change 
Entrapment efficiency 
(%) 
88.95±0.217  
 
88.064±0.652  87.832±0.931  
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Table No. 9: Result of In Vitro release studies of IPN hydrogel (A-10) for stability studies at 
refrigeration temperature (4°C ± 2°C) 
Time( hrs)  
 
2 Month 4 month 6 month 
0 0 0 0 
1 5.030±0.12  4.831±0.21  4.124±0.11  
2 6.021±0.18  5.211±0.34  4.9.±0.36  
3 8.168±0.56  8.018±0.52  7.219±0.35  
4 9.803±0.74  9.091±0.72  8.097±0.51  
6 14.123±0.79  14.002±0.72  13.854±0.84  
8 18.187±1.32  18.132±1.23  17.087±1.09  
12 24.997±1.31  24.01±1.14  23.937±1.81  
18 40.289±1.78  40.056±1.00  39.852±1.22  
24 58.029±1.71  57.998±1.51  57.476±1.34  
30 73.342±1.34.  73.25±1.71  72.860±1.56  
36 96.013±1.72  95.43±1.64  95.01±1.28 
 
 
Table no. 10: Result of In Vitro release studies of IPN hydrogel (A-10) for stability studies at 
25°C±2°C /60% ± 5% RH 
Time( hrs)  
 
2 Month 4 month 6 month 
0 0 0 0 
1 5.001±0.38  4.236±0.54  3451.±0.12  
2 6.098±0.42  5.327±0.76  4.657±0.79  
3 8.098±0.23  7.659±0.32  6.538±0.21  
4 9.006±0.13  9.675±0.95  8.234±0.86  
6 14.021±0.34  13.086±0.83  12.760±0.47  
8 18.129±1.03  17.761±1.46  16.645±1.21  
12 24.921±1.23  24.661±1.19  23.021±1.05  
18 40.761±1.54  39.976±1.61  39.018±1.95  
24 58.098±1.23  57.298±1.42  57.01±1.55  
30 74.091±1.76.  73.893±1.35  72.067±1.70  
36 96.0±1.10  95.870±0.91  94.043±0.72  
 
Table 11: Result of In Vitro release studies of IPN hydrogel (A-10) for stability studies at 40° 
C±2°C 75% ±5 % RH 
Time( hrs)  
 
2 Month 4 month 6 month 
0 0 0 0 
1 4.212±0.98  3.876±0.01  2.553±0.87  
2 5.327±0.53  4.567±0.98  3.012±0.19  
4 9.091±0.65  8.087±0.56  6.022±0.96  
6 13.545±0.76  12.673±1.43  11.432±1.01  
8 16.961±1.21  16.094±1.07  15.995±1.05  
12 24.980±1.871  24.347±1.77  23.018±1.98  
18 40.741±1.21  39.089±1.81  38.261±1.03  
24 58.012±1.11  57.342±1.76  56.913±1.41  
30 73.098±1.17.  72.665±1.23  71.006±1.19  
36 96.001±0.91  95.080±1.27  93.078±0.82 
 
Conclusion 
 
Interpenetrating polymer network hydrogel were 
prepared by chemical cross linking method. We 
made twelve different formulations. Out of all the 
twelve formulation A-10 formulation is optimized 
and taken for further characterization. Polymers, 
drug as well as the optimized formulation were 
characterized by Fourier transfer infrared 
spectroscopy to know any possible interaction 
between drug, polymer and the cross linking agent. 
The peaks were well maintained in formulation 
which is present in exicipients and drug confirms 
the stability of the drug in the formulation. The 
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morphology of cefadroxil loaded IPN Hydrogel 
formulations were examined by SEM and results 
shows that the unswollen IPN Hydrogel appeared 
to be in smooth surface. XRD patterns recorded for 
plain drug and drug loaded Interpenetrating 
polymer network hydrogel. From the swelling 
studies it is concluded that IPN hydrogel which is 
formulated can absorb large amount of water and 
have good swelling property. The data obtained 
from the dissolution profile of IPN hydrogel was 
fitted into various mathematical models and the 
data was found to fit best into the zero order 
release model, which suggests that the mechanism 
of drug release was constant or independent of 
concentration. Results of stability studies have 
shown that all the IPN hydrogel formulations were 
stable at 4°C ± 2°C, 25°C±2°C /60% ±5% RH and 
40° C±2°C / 75%±5% RH but slightly decrease in 
Entrapment efficiency and Percentage cumulative 
drug release was observed in this order 4°C ± 
2°C>25°C±2°C /60% ±5% RH >40° C±2°C / 
75%±5% RH. There was no any change in Physical 
appearance at all three conditions. These result 
suggest that IPN hydrogel are more stable in 4°C ± 
2°C as compare to 25°C±2°C /60% ±5% RH and 
40° C±2°C / 75%±5% RH. 
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